Gautam Patel Sells $664K of Amneal Pharmaceuticals Inc (AMRX) — SEC Form 4, Apr 02, 2025

Open-Market Net Sale · SEC Form 4

−$664,000

10b5-1 Plan

Equity position changed by -4.4%

Reporting Owner

Gautam Patel

Director

TXN 2025-04-01 · FILED 2025-04-02

Equity Position 1.73M sh 1,808,886 → 1,728,886

Equity Change -4.4% shares held after vs before

Filing Lag 1 business day within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Amneal Pharmaceuticals Inc

AMRX CIK 0001723128

Reporting Owner

Name	Relationship
Gautam Patel CIK 0001738054	Director

Gautam Patel at Amneal Pharmaceuticals Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Amneal Pharmaceuticals Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Class A Common StockF1	2025-04-01	S - Sale 10b5-1	80,000 D	$8.30	-$664,000	1,728,886	Direct

Footnotes (1)

F1: These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on August 15, 2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.17 to $8.43 per share, inclusive. The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 6 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Amneal Pharmaceuticals Inc

GET /v1/forms/4/0001628280-25-016184 API docs